Nancy L. Moureau and Russ Nassof

Nancy L. Moureau, RN, PhD, BSN, CRNI, CPUI, VA-BC, is CEO and Educational Specialist for PICC Excellence, Inc., which provides education, consulting, and research on vascular access devices. Dr. Moureau is an internationally recognized speaker on Peripherally Inserted Central Catheters (PICCs) and issues of vascular access practice.

Russ Nassof, JD the Founder and EVP of RiskNomics LLC, has more than 25 years of experience in environmental/healthcare risk consulting, focused on infection control, microbial contamination, toxic tort risk management, insurance defense, wildfire impact claims, and industrial hygiene.

Posts by Nancy L. Moureau and Russ Nassof

Why We Need a New Category for Safety Devices

Creating a category for technologies like the safety release valve would confer benefits, including improved patient safety, reduced costs for the healthcare system overall, and lowered liability risk.

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.